Are high drug prices for hematologic malignancies justified? A critical analysis

E-ISSN： 1097-0142|121|19|3372-3379

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.19, 2015-10, pp. : 3372-3379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The dilemma of high drug prices

JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH (ELECTRONIC), Vol. 6, Iss. 4, 2015-12 ,pp. : 169-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

FISH panels for hematologic malignancies

Cytogenetic and Genome Research, Vol. 118, Iss. 2-4, 2007-11 ,pp. : 284-296

Karger

Access to resources Recommend Favorite

Elevation of Activated Platelet-Dependent Chemokines and Soluble Cell Adhesion Molecules in Patients with Hematologic Malignancies and High Levels of β-D-Glucan

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 1, 2008-03 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Nelarabine- A New Purine Analog in the Treatment of Hematologic Malignancies

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 185-192

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma concentration of micafungin in patients with hematologic malignancies

By Nakagawa Yasunori Ichii Yoko Saeki Yasuhiro Kodaka Masanobu Suzuki Kenshi Kishino Satoshi

Journal of Infection and Chemotherapy, Vol. 13, Iss. 1, 2007-02 ,pp. : 39-45

Springer Publishing Company

Access to resources Recommend Favorite